70 related articles for article (PubMed ID: 14550308)
1. Metallothionein 2A interacts with the kinase domain of PKCmu in prostate cancer.
Rao PS; Jaggi M; Smith DJ; Hemstreet GP; Balaji KC
Biochem Biophys Res Commun; 2003 Oct; 310(3):1032-8. PubMed ID: 14550308
[TBL] [Abstract][Full Text] [Related]
2. Interaction between protein kinase Cmu and the vanilloid receptor type 1.
Wang Y; Kedei N; Wang M; Wang QJ; Huppler AR; Toth A; Tran R; Blumberg PM
J Biol Chem; 2004 Dec; 279(51):53674-82. PubMed ID: 15471852
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C mu is down-regulated in androgen-independent prostate cancer.
Jaggi M; Rao PS; Smith DJ; Hemstreet GP; Balaji KC
Biochem Biophys Res Commun; 2003 Jul; 307(2):254-60. PubMed ID: 12859948
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells.
Yamasaki M; Nomura T; Sato F; Mimata H
Oncol Rep; 2007 Nov; 18(5):1145-53. PubMed ID: 17914565
[TBL] [Abstract][Full Text] [Related]
5. p32 (gC1qBP) is a general protein kinase C (PKC)-binding protein; interaction and cellular localization of P32-PKC complexes in ray hepatocytes.
Robles-Flores M; Rendon-Huerta E; Gonzalez-Aguilar H; Mendoza-Hernandez G; Islas S; Mendoza V; Ponce-Castaneda MV; Gonzalez-Mariscal L; Lopez-Casillas F
J Biol Chem; 2002 Feb; 277(7):5247-55. PubMed ID: 11698413
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C mu is negatively regulated by 14-3-3 signal transduction proteins.
Hausser A; Storz P; Link G; Stoll H; Liu YC; Altman A; Pfizenmaier K; Johannes FJ
J Biol Chem; 1999 Apr; 274(14):9258-64. PubMed ID: 10092600
[TBL] [Abstract][Full Text] [Related]
7. ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosis.
Cui Y; Wang J; Zhang X; Lang R; Bi M; Guo L; Lu SH
Biochem Biophys Res Commun; 2003 Mar; 302(4):904-15. PubMed ID: 12646258
[TBL] [Abstract][Full Text] [Related]
8. Regulation of protein kinase Cmu by basic peptides and heparin. Putative role of an acidic domain in the activation of the kinase.
Gschwendt M; Johannes FJ; Kittstein W; Marks F
J Biol Chem; 1997 Aug; 272(33):20742-6. PubMed ID: 9252396
[TBL] [Abstract][Full Text] [Related]
9. Association of protein kinase Cmu with type II phosphatidylinositol 4-kinase and type I phosphatidylinositol-4-phosphate 5-kinase.
Nishikawa K; Toker A; Wong K; Marignani PA; Johannes FJ; Cantley LC
J Biol Chem; 1998 Sep; 273(36):23126-33. PubMed ID: 9722541
[TBL] [Abstract][Full Text] [Related]
10. Cloning and expression analysis of a protein kinase C gene, PKCmu, and its regulation of the promoter region in zebrafish.
Chen JY; Wei CC; Chiou MJ; Su HY; Kuo CM
DNA Cell Biol; 2007 Jun; 26(6):415-24. PubMed ID: 17570765
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein 2A expression is associated with cell proliferation in breast cancer.
Jin R; Chow VT; Tan PH; Dheen ST; Duan W; Bay BH
Carcinogenesis; 2002 Jan; 23(1):81-6. PubMed ID: 11756227
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein 2A an interactive protein linking phosphorylated FADD to NF-κB pathway leads to colorectal cancer formation.
Marikar FM; Jin G; Sheng W; Ma D; Hua Z
Chin Clin Oncol; 2016 Dec; 5(6):76. PubMed ID: 28061540
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein 3: an androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells.
Juang HH; Chung LC; Sung HC; Feng TH; Lee YH; Chang PL; Tsui KH
Prostate; 2013 Oct; 73(14):1495-506. PubMed ID: 23794209
[TBL] [Abstract][Full Text] [Related]
14. A retroviral-derived peptide phosphorylates protein kinase D/protein kinase Cmu involving phospholipase C and protein kinase C.
Luangwedchakarn V; Day NK; Hitchcock R; Brown PG; Lerner DL; Rucker RP; Cianciolo GJ; Good RA; Haraguchi S
Peptides; 2003 May; 24(5):631-7. PubMed ID: 12895647
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer.
Jaggi M; Rao PS; Smith DJ; Wheelock MJ; Johnson KR; Hemstreet GP; Balaji KC
Cancer Res; 2005 Jan; 65(2):483-92. PubMed ID: 15695390
[TBL] [Abstract][Full Text] [Related]
16. Silencing the Metallothionein-2A gene inhibits cell cycle progression from G1- to S-phase involving ATM and cdc25A signaling in breast cancer cells.
Lim D; Jocelyn KM; Yip GW; Bay BH
Cancer Lett; 2009 Apr; 276(1):109-17. PubMed ID: 19062161
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of metallothionein isoforms in nasopharyngeal cancer and inhibition of cell growth by antisense down-regulation of metallothionein-2A.
Tan OJ; Bay BH; Chow VT
Oncol Rep; 2005 Jan; 13(1):127-31. PubMed ID: 15583813
[TBL] [Abstract][Full Text] [Related]
18. Domain shuffling as a tool for investigation of protein function: substitution of the cysteine-rich region of Raf kinase and PKC eta for that of yeast Pkc1p.
Schmitz HP; Jöckel J; Block C; Heinisch JJ
J Mol Biol; 2001 Aug; 311(1):1-7. PubMed ID: 11469853
[TBL] [Abstract][Full Text] [Related]
19. NoBP, a nuclear fibroblast growth factor 3 binding protein, is cell cycle regulated and promotes cell growth.
Reimers K; Antoine M; Zapatka M; Blecken V; Dickson C; Kiefer P
Mol Cell Biol; 2001 Aug; 21(15):4996-5007. PubMed ID: 11438656
[TBL] [Abstract][Full Text] [Related]
20. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells.
Abdel-Mageed A; Agrawal KC
Cancer Gene Ther; 1997; 4(3):199-207. PubMed ID: 9171939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
